12:00 AM
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Deals

Cephalon, Champions Biotechnology deal

Champions will use its Biomerk Tumorgraft technology to test the efficacy of Cephalon's BRAF...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >